287.91 USD
↗ 0.06 (0.02%)PRE MARKET (AS OF 07:18 AM EDT)
Ligand Pharmaceuticals Inc.
LGNDNASDAQ • USD
Market: OPEN
Shares of Ligand Pharmaceuticals Inc. (LGND) are trading at $287.91. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, exceptional Return on Equity (20.4%) and a bullish Golden Cross on the moving averages. Furthermore, LGND is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 26, 2026.
Open?$287.91
High?$287.91
Low?$287.91
Prev. Close?$287.85
Volume?121
Avg. Volume?259.9K
VWAP?$287.91
Rel. Volume?0.00x
Bid / Ask
Bid?$245.65 × 100
Ask?$366.82 × 100
Spread?$121.17
Midpoint?$306.24
Valuation & Ratios
Market Cap?5.7B
Shares Out?19.9M
Float?18.9M
Float %?94.2%
P/E Ratio?29.10
P/B Ratio?5.93
EPS?$9.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Address
3911 SORRENTO VALLEY BLVD
SAN DIEGO, CA 92121
Phone: 858-550-7500
SAN DIEGO, CA 92121
Phone: 858-550-7500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?94
Momentum?50
Short Sent.?49
Piotroski F-Score?5/9Mixed
Altman Z-Score?4.25Safe
Confidence?68%Moderate
Short InterestHigh
Short % of Float?12.97%High
Short Interest?2.4M
Days to Cover?8.8
Free Float18.9M
Avg Daily Volume279.4K
Settlement Date2026-08-14
Financial Health
Current Ratio?31.18Strong
Quick Ratio?30.96Strong
Cash Ratio?21.54Strong
Debt/Equity?1.16Moderate
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score44/100
P/E?29.1FAIR▾
Peers33
S&P36
P/B?5.93FAIR▾
Peers33
S&P31
P/S?19.75HIGH▾
Peers33
S&P3
P/FCF?44.6PRICEY▾
Peers33
S&P14
EV/EBITDA?44.0HIGH▾
Peers33
S&P3
EV/Sales?20.16HIGH▾
Peers33
S&P3
Returns & Efficiency
ROE?20.4%STRONG▾
Peers67
S&P67
ROA?9.0%STRONG▾
Peers67
S&P71
Cash Flow & Enterprise
FCF?$128.8M
Enterprise Value?$5.9B
Fundamentals ratios updated end of day